Notable Analyst Rating Changes 9/8: GS, AMD, RIMM, NLY Upgraded; AZO, NOK, RFMD, GSK Downgraded
More News related to ABB
- Viterra and ABB to Implement Grain Volume Insurance and Remove Volume Variation Fee
- Viterra and ABB to Implement Grain Volume Insurance and Remove Volume Variation Fee
- Baird Initiates Coverage on ABB Ltd (ABB) with an Outperform
- Viterra Inc.: Update on the Foreign Investment Review Board Process
- Viterra Inc.: Update on the Foreign Investment Review Board Process
More News related to AMD
- David Moenning’s Daily State of the Markets: 7/2
- NVIDIA (NVDA) Falls On Share Loss Rumors
- AMD Continues to Drive Industry Adoption of GPU Acceleration in Enterprise and HPC Environments
- GLOBALFOUNDRIES Announces New Fab 2 Executive Leadership Team
- The 'Best-of-the-Best' Supercomputers Leverage AMD Opteron(TM) Processors
More News related to AZO
- ALLDATA(r) Training is a Priority in Its "Virtual Classroom"
- FBR Capital Comments On Lampert's AutoZone (AZO) Sales
- AutoZone (AZO) Largest Holder Eddie Lampert's Trims 450K Shares
- 10 Stocks Taking Care of Investors: No. 2 AutoZone (AZO)
- After-Hours Movers 6/17: LVLT, LGF, SIRI, AZO Higher; IMGN, SOA, HPT, CLC Lower
UPGRADES:
Merrill Lynch upgrades Goldman Sachs (NYSE: GS) to Buy and Lehman Brothers (NYSE: LEH) to Neutral.
Banc of America upgrades Advanced Micro Devices Inc. (NYSE: AMD) from Sell to Neutral with a $6 price target.
Morgan Keegan upgrades Research In Motion (Nasdaq: RIMM) from Market Perform to Outperform.
Credit Suisse upgrades Annaly Capital (NYSE: NLY) from Neutral to Outperform.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Goldman Sachs downgrades AutoZone Inc. (NYSE: AZO) from Buy to Neutral and removes the stock from its Conviction Buy List.
Deutsche Bank downgrades Nokia (NYSE: NOK) from Buy to Hold. The firm also lowered its price target from Euro25 to Euro16.
Citi downgrades RF Micro Devices (Nasdaq: RFMD) from Buy to Hold. Price target $3.80.
Goldman Sachs downgrades GlaxoSmithKline (NYSE: GSK) from Neutral to Sell.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Morgan Stanley initiates coverage on Genzyme (Nasdaq: GENZ) with an Overweight rating. Price target $94.
Credit Suisse initiates coverage on ABB Ltd (NYSE: ABB) with an Underperform.
Credit Suisse initiates coverage on Philips Electronics (NYSE: PHG) with an Outperform.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+10.17
-124.12Related Entities
- Goldman Sachs Conviction Buy List
- Credit Suisse
- Deutsche Bank
- Goldman Sachs
- Citi
- Morgan Stanley
- Merrill Lynch
- Lehman Brothers
- Banc of America
- Morgan Keegan & Company
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
